Filing Details
- Accession Number:
- 0001551986-18-000025
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-08-30 20:38:25
- Reporting Period:
- 2018-08-28
- Accepted Time:
- 2018-08-30 20:38:25
- Original Submission Date:
- 2018-08-28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551986 | Innovate Biopharmaceuticals Inc. | INNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1721664 | Sandeep Laumas | C/O Innovate Biopharmaceuticals, Inc. 8480 Honeycutt Road, Suite 120 Raleigh NC 27615 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-28 | 250 | $4.90 | 250 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 758,373 | Indirect | By Bearing Circle Capital LLC |
Footnotes
- These shares were inadvertently omitted from the original Form 4.
- These shares, which were previously reported, were inadvertently omitted from the original Form 4.
- These shares are held by Bearing Circle Capital LLC. Dr. Laumas is affiliated with Bearing Circle Capital LLC and has voting and investment power over the shares held by Bearing Circle Capital LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.